Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Equillium (EQ) EBITDA (2022 - 2025)

Equillium (EQ) has disclosed EBITDA for 4 consecutive years, with -$3.7 million as the latest value for Q4 2025.

  • Quarterly EBITDA rose 26.51% to -$3.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$22.8 million through Dec 2025, down 207.24% year-over-year, with the annual reading at -$22.8 million for FY2025, 207.24% down from the prior year.
  • EBITDA for Q4 2025 was -$3.7 million at Equillium, up from -$4.3 million in the prior quarter.
  • The five-year high for EBITDA was $2.7 million in Q4 2022, with the low at -$37.7 million in Q1 2022.
  • Average EBITDA over 4 years is -$6.6 million, with a median of -$3.7 million recorded in 2023.
  • The sharpest move saw EBITDA soared 108.95% in 2024, then plummeted 2155.74% in 2025.
  • Over 4 years, EBITDA stood at $2.7 million in 2022, then plummeted by 200.15% to -$2.7 million in 2023, then crashed by 88.35% to -$5.0 million in 2024, then rose by 26.51% to -$3.7 million in 2025.
  • According to Business Quant data, EBITDA over the past three periods came in at -$3.7 million, -$4.3 million, and -$6.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.